Dominant SCN1B mutations are known to cause several epilepsy syndromes in humans.
Only 2 epilepsy patients to date have been reported to have recessive mutations in SCN1B as …

Background Levetiracetam is a relatively new-generation antiseizure drug approved for the
treatment of focal and generalized seizures. Despite its favorable side effect profile and …

Objectives: To compare the efficacy and safety of corpus callosotomy versus vagus nerve
stimulation (VNS) as long-term adjunctive therapies in children with Lennox–Gastaut syndrome…

Purpose Asparagine synthetase deficiency (ASNSD) is a rare neurometabolic disease.
Patients may not demonstrate low asparagine levels, which highlights the advantage of …

Objectives: To report the existence and describe the non-epileptic abnormalities, interictal
epileptiform discharges, and seizures in routine electroencephalograms (EEGs) of infants in a …

Several patients are referred to the epilepsy monitoring unit (EMU) to evaluate episodic events
that can be challenging to differentiate from epileptic events. The current study aimed to …

Background: Vagus nerve stimulation (VNS) is a treatment mainly approved as an adjuvant
toantiepileptic drugs for therapy-resistant focal epilepsy. Currently, its use is expanded to …

Methods A prospective cohort study of 73 medical professionals from KFMC was performed,
with sample size having been determined by a biostatistician as sufficient to determine the …

Objective: To enhance early recognition of SEPN-1 related myopathy in causing unexplained
respiratory insufficiency. Background: Recessive mutations in the Selenoprotein N1 (…

Objective: To illustrate the phenotypic heterogeneity of a homozygous COLQ mutation , its
clinical findings and neurophysiological features. Background: Congenital myasthenic …